| | Cancer | Cancer Treatment

Understanding Cancer: Development, Spread, and Treatment

Cancer is a group of diseases characterized by uncontrolled cell growth with potential to invade and metastasize. It arises from genetic and epigenetic alterations that disrupt normal cellular regulation.

Hallmarks of Cancer (Hanahan & Weinberg)

Sustaining proliferative signaling
Evading growth suppressors
Resisting cell death (apoptosis)
Enabling replicative immortality (telomerase)
Inducing angiogenesis
Activating invasion and metastasis
Reprogramming energy metabolism (Warburg effect)
Evading immune destruction
Genome instability and mutation
Tumor-promoting inflammation

Common Cancer Types and Origins

Cancer	Cell of Origin	Key Risk Factors
Breast	Ductal/lobular epithelium	Female, age, genetics (BRCA), hormones, density, alcohol, obesity
Lung	Bronchial epithelium	Smoking (85%), radon, asbestos, air pollution
Colorectal	Colonic mucosa	Age, polyps, IBD, family history, diet (red/processed meat), obesity, inactivity
Prostate	Prostatic epithelium	Age, African ancestry, family history, genetics
Skin (melanoma)	Melanocytes	UV exposure, fair skin, nevi, family history, immunosuppression

Carcinogenesis: From Initiation to Metastasis

Initiation: DNA damage (carcinogens, radiation, viruses, replication errors) → mutation in oncogene/tumor suppressor.
Promotion: Clonal expansion of initiated cell (hormones, inflammation, promoters).
Progression: Accumulation of additional mutations → increasing malignancy, heterogeneity.
Invasion: Breach basement membrane; EMT; degrade ECM (MMPs).
Intravasation: Enter lymphatics/bloodstream.
Circulation: Survive shear stress, immune attack (CTCs).
Extravasation: Exit at distant site.
Colonization: Adapt to new microenvironment; establish metastatic niche.

Major Risk Factor Categories

Age: Accumulated mutations, declining DNA repair, immune senescence.
Genetics: Inherited mutations (high/penetrance); polygenic risk.
Lifestyle: Tobacco (22% of cancer deaths), alcohol, diet (low fiber, high processed meat), obesity, inactivity, UV exposure.
Environmental/Occupational: Asbestos, benzene, arsenic, radon, formaldehyde, shift work (circadian disruption).
Infections: HPV (cervical, oropharyngeal), HBV/HCV (liver), H. pylori (gastric), EBV (lymphoma, nasopharyngeal), HIV (Kaposi, lymphoma).
Medical: Immunosuppression, prior chemo/radiation, HRT, DES.

Treatment Modalities

Surgery: Curative for localized solid tumors; staging; palliation.
Radiation: Curative (definitive), adjuvant, neoadjuvant, palliative; techniques: IMRT, SBRT, proton, brachytherapy.
Systemic therapy:
- Chemotherapy (cytotoxic)
- Targeted therapy (kinase inhibitors, mAbs, ADCs)
- Immunotherapy (checkpoint inhibitors, CAR-T, vaccines)
- Hormonal therapy (breast, prostate)
Multimodal: Most curative regimens combine modalities.

Prevention and Early Detection

Primary prevention: Tobacco control, HPV/HBV vaccination, sun protection, healthy diet/weight/activity, alcohol moderation, occupational safety.
Secondary prevention (screening): Mammography, LDCT (lung), colonoscopy/FIT (colorectal), Pap/HPV (cervical), PSA (shared decision), skin exams.
Tertiary prevention: Survivorship care, recurrence surveillance, second cancer screening.

Outlook

Overall 5-year relative survival: 68% (all sites). Varies widely: prostate 97%, breast 90%, colorectal 65%, lung 23%, pancreatic 12%. Precision oncology, immunotherapy, early detection (liquid biopsy, AI imaging), and prevention are improving outcomes. Cancer is increasingly a chronic, manageable condition for many.